♡🦋قمـ ꙰🌙⑅⃝𝄞ـر🦋♡
Region: TR
Monday 15 June 2026 19:43:34 GMT
19609
1282
0
928
Music
Download
Comments
There are no more comments for this video.
To see more videos from user @q.a.m.a.r00, please go to the Tikwm
homepage.
![#sponsored Visit @airsuprahcp_risks for full Important Safety Information and Prescribing Information, including Patient Information. Seasonal asthma triggers may be impacting your patients with asthma. As healthcare providers, we should not only treat our patient’s symptoms but also help them prevent an exacerbation. That’s why I’m partnering with AIRSUPRA, the first and only FDA-approved anti-inflammatory rescue that treats bronchoconstriction and helps prevent exacerbations. Don’t wait - prescribe AIRSUPRA today and learn more at airsupraHCP.com AIRSUPRA contains albuterol (SABA) for rapid bronchodilation + budesonide (ICS) to address inflammation #AIRSUPRA #AstraZenecaPartner [@airsupra_albuterol_budesonide] Important Product Information AIRSUPRA is an as-needed rescue inhaler for patients with asthma ≥18 years old. NOT for maintenance use. Patients should be monitored for asthma deterioration. AIRSUPRA can produce life threatening paradoxical bronchospasm, or clinically significant cardiovascular effects—discontinue as needed. Hypokalemia, infections, oropharyngeal candidiasis, and hypersensitivity reactions, including anaphylaxis can occur. SABA, short-acting β2-agonist; ICS, inhaled corticosteroid. References Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2025. Accessed January 9, 2026. www.ginasthma.org AIRSUPRA® (albuterol/budesonide) [prescribing information]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2025. US FDA. Published January 11, 2023. Accessed January 9, 2026. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-combination-treatment-adults-asthma](/video/cover/7635022868799081742.webp)
